Centessa Pharmaceuticals (UK) Limited
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Centessa Pharmaceuticals (UK) Limited sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Centessa Pharmaceuticals (UK) Limited: 6 sponsored US clinical trials, 5 recruiting.
Centessa Pharmaceuticals (UK) Limited sponsors 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Narcolepsy Type 1, with 2 trials.
Upper-quartile sponsor footprint
Centessa Pharmaceuticals (UK) Limited sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
NCT07598708
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
NCT07413666
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT07096674
A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
NCT07082829
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT06752668
A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
NCT05821777
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Centessa Pharmaceuticals (UK) Limited pipeline
5 recruiting of 6 indexed (83% open).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Narcolepsy Type 1 (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Centessa Pharmaceuticals (UK) Limited: open-pipeline peers nationwide
Peers matched on 6 registered trials and 83% open enrollment, not the therapeutic-area sidebar.
Centessa Pharmaceuticals (UK) Limited sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 83% open enrollment (± trial volume)
- Meyer Children's Hospital IRCCS · 83% recruiting · 6 trials
- SystImmune · 83% recruiting · 6 trials
- Tyra Biosciences · 83% recruiting · 6 trials
- Johnson & Johnson Enterprise Innovation · 86% recruiting · 7 trials
Related
What to do with this Centessa Pharmaceuticals (UK) Limited page
6 registered trials is a research-attention snapshot, not an endorsement of Centessa Pharmaceuticals (UK) Limited or any single study.
- 5 of Centessa Pharmaceuticals (UK) Limited's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Narcolepsy Type 1 is the condition Centessa Pharmaceuticals (UK) Limited studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Narcolepsy Type 1 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Centessa Pharmaceuticals (UK) Limited pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.